Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won't cause a person to come on.
This report aims to provide a comprehensive presentation of the global market for Live Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Vaccines. This report contains market size and forecasts of Live Vaccines in global, including the following market information:
Global Live Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Live Vaccines Market Sales, 2018-2023, 2024-2030, (K Doses)
Global top five Live Vaccines companies in 2022 (%)
The global Live Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Monovalent Live Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Live Vaccines include Merck, GlaxoSmithKline, Pfizer, Novartis, Astellas Pharma, Emergent BioSolutions and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Live Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Vaccines Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Live Vaccines Market Segment Percentages, by Type, 2022 (%)
Monovalent Live Vaccines
Multivalent Live Vaccines
Global Live Vaccines Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Live Vaccines Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Live Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Live Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Vaccines revenues share in global market, 2022 (%)
Key companies Live Vaccines sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Live Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GlaxoSmithKline
Pfizer
Novartis
Astellas Pharma
Emergent BioSolutions
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Live Vaccines, market overview.
Chapter 2: Global Live Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Live Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Live Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Live Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Live Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Vaccines Overall Market Size
2.1 Global Live Vaccines Market Size: 2022 VS 2030
2.2 Global Live Vaccines Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Live Vaccines Sales: 2018-2030
3 Company Landscape
3.1 Top Live Vaccines Players in Global Market
3.2 Top Global Live Vaccines Companies Ranked by Revenue
3.3 Global Live Vaccines Revenue by Companies
3.4 Global Live Vaccines Sales by Companies
3.5 Global Live Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Live Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Vaccines Market Size Markets, 2022 & 2030
4.1.2 Monovalent Live Vaccines
4.1.3 Multivalent Live Vaccines
4.2 By Type - Global Live Vaccines Revenue & Forecasts
4.2.1 By Type - Global Live Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Live Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Live Vaccines Revenue Market Share, 2018-2030
4.3 By Type - Global Live Vaccines Sales & Forecasts
4.3.1 By Type - Global Live Vaccines Sales, 2018-2023
4.3.2 By Type - Global Live Vaccines Sales, 2024-2030
4.3.3 By Type - Global Live Vaccines Sales Market Share, 2018-2030
4.4 By Type - Global Live Vaccines Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live Vaccines Market Size, 2022 & 2030
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Live Vaccines Revenue & Forecasts
5.2.1 By Application - Global Live Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Live Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Live Vaccines Revenue Market Share, 2018-2030
5.3 By Application - Global Live Vaccines Sales & Forecasts
5.3.1 By Application - Global Live Vaccines Sales, 2018-2023
5.3.2 By Application - Global Live Vaccines Sales, 2024-2030
5.3.3 By Application - Global Live Vaccines Sales Market Share, 2018-2030
5.4 By Application - Global Live Vaccines Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Live Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Live Vaccines Revenue & Forecasts
6.2.1 By Region - Global Live Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Live Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Live Vaccines Revenue Market Share, 2018-2030
6.3 By Region - Global Live Vaccines Sales & Forecasts
6.3.1 By Region - Global Live Vaccines Sales, 2018-2023
6.3.2 By Region - Global Live Vaccines Sales, 2024-2030
6.3.3 By Region - Global Live Vaccines Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Live Vaccines Revenue, 2018-2030
6.4.2 By Country - North America Live Vaccines Sales, 2018-2030
6.4.3 US Live Vaccines Market Size, 2018-2030
6.4.4 Canada Live Vaccines Market Size, 2018-2030
6.4.5 Mexico Live Vaccines Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Live Vaccines Revenue, 2018-2030
6.5.2 By Country - Europe Live Vaccines Sales, 2018-2030
6.5.3 Germany Live Vaccines Market Size, 2018-2030
6.5.4 France Live Vaccines Market Size, 2018-2030
6.5.5 U.K. Live Vaccines Market Size, 2018-2030
6.5.6 Italy Live Vaccines Market Size, 2018-2030
6.5.7 Russia Live Vaccines Market Size, 2018-2030
6.5.8 Nordic Countries Live Vaccines Market Size, 2018-2030
6.5.9 Benelux Live Vaccines Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Live Vaccines Revenue, 2018-2030
6.6.2 By Region - Asia Live Vaccines Sales, 2018-2030
6.6.3 China Live Vaccines Market Size, 2018-2030
6.6.4 Japan Live Vaccines Market Size, 2018-2030
6.6.5 South Korea Live Vaccines Market Size, 2018-2030
6.6.6 Southeast Asia Live Vaccines Market Size, 2018-2030
6.6.7 India Live Vaccines Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Live Vaccines Revenue, 2018-2030
6.7.2 By Country - South America Live Vaccines Sales, 2018-2030
6.7.3 Brazil Live Vaccines Market Size, 2018-2030
6.7.4 Argentina Live Vaccines Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Vaccines Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Live Vaccines Sales, 2018-2030
6.8.3 Turkey Live Vaccines Market Size, 2018-2030
6.8.4 Israel Live Vaccines Market Size, 2018-2030
6.8.5 Saudi Arabia Live Vaccines Market Size, 2018-2030
6.8.6 UAE Live Vaccines Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Live Vaccines Major Product Offerings
7.1.4 Merck Live Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Summary
7.2.2 GlaxoSmithKline Business Overview
7.2.3 GlaxoSmithKline Live Vaccines Major Product Offerings
7.2.4 GlaxoSmithKline Live Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Live Vaccines Major Product Offerings
7.3.4 Pfizer Live Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Live Vaccines Major Product Offerings
7.4.4 Novartis Live Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Astellas Pharma
7.5.1 Astellas Pharma Company Summary
7.5.2 Astellas Pharma Business Overview
7.5.3 Astellas Pharma Live Vaccines Major Product Offerings
7.5.4 Astellas Pharma Live Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Astellas Pharma Key News & Latest Developments
7.6 Emergent BioSolutions
7.6.1 Emergent BioSolutions Company Summary
7.6.2 Emergent BioSolutions Business Overview
7.6.3 Emergent BioSolutions Live Vaccines Major Product Offerings
7.6.4 Emergent BioSolutions Live Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Emergent BioSolutions Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Live Vaccines Major Product Offerings
7.7.4 AstraZeneca Live Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
8 Global Live Vaccines Production Capacity, Analysis
8.1 Global Live Vaccines Production Capacity, 2018-2030
8.2 Live Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Vaccines Supply Chain Analysis
10.1 Live Vaccines Industry Value Chain
10.2 Live Vaccines Upstream Market
10.3 Live Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Live Vaccines in Global Market
Table 2. Top Live Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Live Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Live Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Live Vaccines Sales by Companies, (K Doses), 2018-2023
Table 6. Global Live Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Live Vaccines Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Live Vaccines Product Type
Table 9. List of Global Tier 1 Live Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Live Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Live Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Live Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Live Vaccines Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Live Vaccines Sales (K Doses), 2018-2023
Table 15. By Type - Global Live Vaccines Sales (K Doses), 2024-2030
Table 16. By Application ? Global Live Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Live Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Live Vaccines Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Live Vaccines Sales (K Doses), 2018-2023
Table 20. By Application - Global Live Vaccines Sales (K Doses), 2024-2030
Table 21. By Region ? Global Live Vaccines Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Live Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Live Vaccines Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Live Vaccines Sales (K Doses), 2018-2023
Table 25. By Region - Global Live Vaccines Sales (K Doses), 2024-2030
Table 26. By Country - North America Live Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Live Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Live Vaccines Sales, (K Doses), 2018-2023
Table 29. By Country - North America Live Vaccines Sales, (K Doses), 2024-2030
Table 30. By Country - Europe Live Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Live Vaccines Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Live Vaccines Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Live Vaccines Sales, (K Doses), 2024-2030
Table 34. By Region - Asia Live Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Live Vaccines Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Live Vaccines Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Live Vaccines Sales, (K Doses), 2024-2030
Table 38. By Country - South America Live Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Live Vaccines Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Live Vaccines Sales, (K Doses), 2018-2023
Table 41. By Country - South America Live Vaccines Sales, (K Doses), 2024-2030
Table 42. By Country - Middle East & Africa Live Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Live Vaccines Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Live Vaccines Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Live Vaccines Sales, (K Doses), 2024-2030
Table 46. Merck Company Summary
Table 47. Merck Live Vaccines Product Offerings
Table 48. Merck Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Live Vaccines Product Offerings
Table 52. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Live Vaccines Product Offerings
Table 56. Pfizer Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Live Vaccines Product Offerings
Table 60. Novartis Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Astellas Pharma Company Summary
Table 63. Astellas Pharma Live Vaccines Product Offerings
Table 64. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Astellas Pharma Key News & Latest Developments
Table 66. Emergent BioSolutions Company Summary
Table 67. Emergent BioSolutions Live Vaccines Product Offerings
Table 68. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Emergent BioSolutions Key News & Latest Developments
Table 70. AstraZeneca Company Summary
Table 71. AstraZeneca Live Vaccines Product Offerings
Table 72. AstraZeneca Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. AstraZeneca Key News & Latest Developments
Table 74. Live Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 75. Global Live Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Live Vaccines Production by Region, 2018-2023 (K Doses)
Table 77. Global Live Vaccines Production by Region, 2024-2030 (K Doses)
Table 78. Live Vaccines Market Opportunities & Trends in Global Market
Table 79. Live Vaccines Market Drivers in Global Market
Table 80. Live Vaccines Market Restraints in Global Market
Table 81. Live Vaccines Raw Materials
Table 82. Live Vaccines Raw Materials Suppliers in Global Market
Table 83. Typical Live Vaccines Downstream
Table 84. Live Vaccines Downstream Clients in Global Market
Table 85. Live Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Live Vaccines Segment by Type in 2022
Figure 2. Live Vaccines Segment by Application in 2022
Figure 3. Global Live Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Live Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Live Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. Live Vaccines Sales in Global Market: 2018-2030 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Live Vaccines Revenue in 2022
Figure 9. By Type - Global Live Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Live Vaccines Revenue Market Share, 2018-2030
Figure 11. By Type - Global Live Vaccines Sales Market Share, 2018-2030
Figure 12. By Type - Global Live Vaccines Price (USD/Dose), 2018-2030
Figure 13. By Application - Global Live Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Live Vaccines Revenue Market Share, 2018-2030
Figure 15. By Application - Global Live Vaccines Sales Market Share, 2018-2030
Figure 16. By Application - Global Live Vaccines Price (USD/Dose), 2018-2030
Figure 17. By Region - Global Live Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Live Vaccines Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Live Vaccines Revenue Market Share, 2018-2030
Figure 20. By Region - Global Live Vaccines Sales Market Share, 2018-2030
Figure 21. By Country - North America Live Vaccines Revenue Market Share, 2018-2030
Figure 22. By Country - North America Live Vaccines Sales Market Share, 2018-2030
Figure 23. US Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Live Vaccines Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Live Vaccines Sales Market Share, 2018-2030
Figure 28. Germany Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. France Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Live Vaccines Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Live Vaccines Sales Market Share, 2018-2030
Figure 37. China Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. India Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Live Vaccines Revenue Market Share, 2018-2030
Figure 43. By Country - South America Live Vaccines Sales Market Share, 2018-2030
Figure 44. Brazil Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Live Vaccines Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Live Vaccines Sales Market Share, 2018-2030
Figure 48. Turkey Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Live Vaccines Revenue, (US$, Mn), 2018-2030
Figure 52. Global Live Vaccines Production Capacity (K Doses), 2018-2030
Figure 53. The Percentage of Production Live Vaccines by Region, 2022 VS 2030
Figure 54. Live Vaccines Industry Value Chain
Figure 55. Marketing Channels
